SRTS
HealthcareSensus Healthcare, Inc.
$4.45
+$0.35 (+8.54%)
Jan 5, 2026
Price History (1Y)
Analysis
Sensus Healthcare, Inc. is a healthcare company that operates in the medical devices industry within the sector of healthcare. The company has a relatively small scale with a market capitalization of $73.16 million and approximately 54 employees. The company's financial health indicates negative profitability, with a net income of -$3,006,000 on revenue of $35.61 million. This results in margins of -8.4% profit margin, 40.8% operating margin, and 48.0% gross margin. Additionally, the company has negative returns on equity and assets at -5.7%, indicating a decline in profitability. The balance sheet shows a debt-to-equity ratio of 0.86 and a cash position of $14.52 million with minimal debt. The valuation context for Sensus Healthcare, Inc. includes a forward P/E of 445.00 and revenue growth of 155.7% year-over-year. However, the company has negative earnings growth at -433.3%. The dividend yield is not applicable, as it is listed as N/A in the provided facts.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.
Visit website →Key Statistics
- Market Cap
- $73.16M
- P/E Ratio
- N/A
- 52-Week High
- $9.08
- 52-Week Low
- $3.03
- Avg Volume
- 103.90K
- Beta
- 1.22
Company Info
- Industry
- Medical Devices
- Exchange
- NCM
- Country
- United States
- Employees
- 54